BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 11207328)

  • 1. Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease.
    Aarsland D; Litvan I; Larsen JP
    J Neuropsychiatry Clin Neurosci; 2001; 13(1):42-9. PubMed ID: 11207328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Applause sign" helps to discriminate PSP from FTD and PD.
    Dubois B; Slachevsky A; Pillon B; Beato R; Villalponda JM; Litvan I
    Neurology; 2005 Jun; 64(12):2132-3. PubMed ID: 15985587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apathy is not depression.
    Levy ML; Cummings JL; Fairbanks LA; Masterman D; Miller BL; Craig AH; Paulsen JS; Litvan I
    J Neuropsychiatry Clin Neurosci; 1998; 10(3):314-9. PubMed ID: 9706539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
    Pellicano C; Assogna F; Cellupica N; Piras F; Pierantozzi M; Stefani A; Cerroni R; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychological deficits in Parkinson's disease patients with visual hallucinations.
    Ramírez-Ruiz B; Junqué C; Martí MJ; Valldeoriola F; Tolosa E
    Mov Disord; 2006 Sep; 21(9):1483-7. PubMed ID: 16705661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease.
    Somme J; Gómez-Esteban JC; Tijero B; Berganzo K; Lezcano E; Zarranz JJ
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1230-3. PubMed ID: 23253819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non-motor symptoms in Parkinson's disease: cognition and behavior].
    Bonnet AM; Czernecki V
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Sep; 11(3):295-304. PubMed ID: 24026132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric symptoms in progressive supranuclear palsy.
    Menza MA; Cocchiola J; Golbe LI
    Psychosomatics; 1995; 36(6):550-4. PubMed ID: 7501785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease.
    Lee YE; Williams DR; Anderson JF
    J Neuropsychol; 2016 Mar; 10(1):1-14. PubMed ID: 25223526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acoustical analysis of speech in progressive supranuclear palsy.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
    Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
    Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tomographic measurements of regional cerebral blood flow in progressive supranuclear palsy and Parkinson's disease.
    Defebvre L; Lecouffe P; Destée A; Houdart P; Steinling M
    Acta Neurol Scand; 1995 Sep; 92(3):235-41. PubMed ID: 7484078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frontal presentation in progressive supranuclear palsy.
    Donker Kaat L; Boon AJ; Kamphorst W; Ravid R; Duivenvoorden HJ; van Swieten JC
    Neurology; 2007 Aug; 69(8):723-9. PubMed ID: 17709703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysomnographic findings, video-based sleep analysis and sleep perception in progressive supranuclear palsy.
    Sixel-Döring F; Schweitzer M; Mollenhauer B; Trenkwalder C
    Sleep Med; 2009 Apr; 10(4):407-15. PubMed ID: 18945638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
    J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
    Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric symptoms of progressive supranuclear palsy in a dementia clinic.
    Yatabe Y; Hashimoto M; Kaneda K; Honda K; Ogawa Y; Yuuki S; Matsuzaki S; Tuyuguchi A; Kashiwagi H; Ikeda M
    Psychogeriatrics; 2011 Mar; 11(1):54-9. PubMed ID: 21447110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating progressive supranuclear palsy from Parkinson's disease by MRI-based dynamic cerebrospinal fluid flow.
    Fukui Y; Hishikawa N; Sato K; Yunoki T; Kono S; Matsuzono K; Nakano Y; Ohta Y; Yamashita T; Deguchi K; Abe K
    J Neurol Sci; 2015 Oct; 357(1-2):178-82. PubMed ID: 26227830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy.
    Borroni B; Alberici A; Agosti C; Cosseddu M; Padovani A
    Int Psychogeriatr; 2009 Jun; 21(3):463-8. PubMed ID: 19323870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.